Weight-loss surgery prep trial pulled before it even started
NCT ID NCT05710263
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aimed to see if blocking blood vessels to part of the stomach (bariatric embolization) could help super obese patients lose weight before sleeve gastrectomy surgery, potentially lowering surgical risks. It planned to enroll patients with a BMI over 50 and at least three risk factors. However, the trial was withdrawn before any participants were enrolled, so no data were collected.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- bariatric embolization (blocking blood vessels to part of the stomach)
- What this could lead to
- If it had worked, this could have pointed toward a safer way to help super obese patients lose weight before surgery, reducing surgical risks.
- What could go wrong
- The trial was withdrawn before any patients enrolled, so no results exist. The approach is experimental and carries risks like bleeding or infection from the embolization procedure.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BARIATRIC SURGERY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Will shedding pounds heal the pancreas? MRI scans seek answers
- A Two-for-One surgery: could tube removal during Weight-Loss surgery slash ovarian cancer risk?
- Can Weight-Loss surgery rewire the Liver's energy engine?
- Could a simple drug cut bleeding risk in weight-loss surgery?
- Blood test clues could flag Weight-Surgery risks
- Can Weight-Loss surgery alter how medications work?